Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Breast Cancer Res Treat. 2023 Apr 15;199(3):589–601. doi: 10.1007/s10549-023-06937-9

Fig. 4.

Fig. 4.

Enriched gene sets among high RET/GDNF tumors relative to non-high RET/GDNF tumors across (A) ESR1, (B) estrogen, and (C) antiestrogen (AE) signaling sets. (D) Heat plot of notable and significantly regulated genes across enriched estrogen, ESR1 and antiestrogen (AE) signaling sets. Enriched gene sets among high RET/GDNF tumors across (E) MYC and (F) MAPK, ERBB2, and KRAS signaling sets.